Suspension criteria
mistakes

Serious problems about safety occur in the trial;The curative efficacy of drugs is too poor or even ineffective and has no clinical value in the trial;Severe mistakes of clinical trial protocol are founded that is difficult to evaluate the efficacy of the drug; or obvious deviation occur in the progress of implementation and it is difficult to evaluate efficacy of the drug if it continues;The sponsor requests the suspension (such as financial reasons, management reasons, etc.);The administrative department cancels the test.